Navigation Links
Chinese SFDA Grants Immtech Fast Track Status
Date:9/27/2007

NEW YORK, Sept. 27 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (Immtech) (Amex: IMM) announced today that the State Food and Drug Administration of the People's Republic of China (SFDA) has granted Immtech's application Fast Track Status for conducting a Phase III clinical trial with pafuramidine, the Company's oral drug candidate for the treatment of Pneumocystis pneumonia (PCP). Pafuramidine is among the first drugs to be considered for Fast Track Status under new and more stringent SFDA rules recently introduced in China. The PCP clinical trial to be conducted in China will be under the US FDA protocol (http://www.sfda.gov.cn).

Eric L. Sorkin, Chairman and Chief Executive Officer of Immtech stated, "This is a significant milestone for Immtech to work in China to accelerate the approval and availability of pafuramidine as a treatment for PCP. As the most populous nation in the world, China is well positioned to support and benefit from important efforts to combat PCP and other devastating infectious diseases."

PCP is a fungal infection in the lungs and can cause potentially life-threatening pneumonia in patients with HIV and other immune-related diseases. An estimated one million adults and children are afflicted with PCP worldwide, and approximately five million more receive prophylaxis.

PCP is one of the most common opportunistic infections in the estimated 42 million AIDS/HIV patients worldwide. There are only a few treatment options for PCP, and patient intolerance of current therapies is a significant problem. In addition, molecular evidence suggests that resistance of Pneumocystis fungus to current therapy is increasing and may res
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD
2. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
3. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
4. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
5. Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
6. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
7. Staphylococcus aureus vaccine development on track ? safe and immunogenic in Phase I clinicaltrials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , Oct. 1, 2014 Quantum ... scaling volume production of photoactive quantum dots for ... . While offering numerous advantages for solar power ... large quantities of quantum dots with which to ... kept them from commercial utilization and acceptance. The ...
(Date:10/1/2014)... Calif. , Oct. 1, 2014 /PRNewswire/ ... ), a clinical-stage biopharmaceutical company focused on ... positive results from its 371 patient Phase ... with constipation-predominant irritable bowel syndrome (IBS-C).  Results ... clinically meaningful improvement in IBS-C symptoms for ...
(Date:10/1/2014)... LAUSANNE , Switzerland , October ... European leader in Clinical Genomics and Next Generation Sequencing ... Solution allowing clinicians to run full cystic fibrosis analysis ... covers the identification and characterisation of all types of ... analytical performance. Until now, it has not ...
Breaking Medicine Technology:Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2
... , BROOKFIELD, Wis. , ... human resources and recruitment outsourcing company, today announced the addition ... Kaiser Permanente Mid-Atlantic States Region, to its Healthcare Advisory Board. ... during this time of monumental change in the healthcare industry. ...
... , MELVILLE, N.Y. , Jan. 25 ... HSIC ), the largest distributor of health care products and services ... of Bradley T. Sheares , Ph.D. to the Company,s Board ... Sheares brings a wealth of health care experience to the Henry ...
Cached Medicine Technology:Pinstripe Welcomes Carrie Harris-Muller To Board 2Pinstripe Welcomes Carrie Harris-Muller To Board 3Pinstripe Welcomes Carrie Harris-Muller To Board 4Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors 2Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors 3Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors 4Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors 5
(Date:10/1/2014)... This October, Request A Test , a leading national ... off all testing for Diabetes . Customers can ... The Center for Disease Control (CDC) reports that 25.8 ... Because many people do not display symptoms, it is ... health problems. Blood testing can help a person screen ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 This weekend Pope ... the elderly. Speaking to 40,000 seniors in St. ... abandonment of the elderly. "Violence against the elderly is ... "How many times are old people just discarded, victims of ... the result of a throw-away culture that is hurting our ...
(Date:10/1/2014)... NB (PRWEB) October 01, 2014 Indosoft, Inc., ... Q-Suite, announces that it has added support for ... Both Sangoma and Indosoft have a history of ... Sangoma's patent-pending technology offers a significant benefit to those ... AMD that is now available to users of Q-Suite. , ...
(Date:10/1/2014)... 2014 To help raise awareness about women’s ... Integrative Medicine, is detailing several tips for women looking to ... to Dr. Cutler, women should start each day with meditation, ... that will help ‘center’ yourself for the rest of the ... , Other health and fitness tips include:, -Drink half ...
(Date:9/30/2014)... at the same time could stop them from becoming ... Cancer Research * today (Wednesday). , ... funded by MedImmune, the global biologics research and development ... combining the two treatments helped the immune system hunt ... the initial radiotherapy in mice with breast, skin and ...
Breaking Medicine News(10 mins):Health News:Request A Test Offers 10% off Diabetes Testing in October 2014 2Health News:Request A Test Offers 10% off Diabetes Testing in October 2014 3Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 2Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 3Health News:Indosoft Announces Q-Suite Support For Sangoma Lyra 2Health News:In Recognition of National Women’s Health and Fitness Day, Cutler Integrative Medicine Details Tips for Living a Healthier and Happier Life 2Health News:Immunotherapy could stop resistance to radiotherapy 2
... ... and the Lake County Health Department targets underserved communities in North Chicago that are ... hundred people who cannot afford treatment. , ... Evanston, IL (PRWeb) July 7, 2010 -- NorthShore ...
... people with HIV/AIDS will provide significant cost savings over ... formal economic analysis led by researchers at the BC ... Care and the University of British Columbia (UBC). ... recently in AIDS , the official journal of ...
... As an ... help evaluate graduate programs to determine if they meet required standards for accreditation. Graduates ... , ... The American Dental Associations Commission ,on Dental Accreditation (CODA) has appointed Joseph R. Cohen, ...
... patients who participate in longer󈝻- to 30-minute discussions prior ... process) better understand the proposed operation, according to ... Journal of the American College of Surgeons . ... "repeat back" their understanding of the procedure was effective ...
... , ... Petter M. Etholm, CEO of Zone Labs, marketers of Zone Diet products, discussed entrepreneurial ... time radio show. , ... Lexington, KY (Vocus) July 7, 2010 -- “America is the land of educational ...
... Gardner HealthDay Reporter , WEDNESDAY, July 7 (HealthDay ... communicated with their doctors via e-mail got better care and ... as a result of the e-mail exchanges included such measures ... report appearing in Health Affairs . The ...
Cached Medicine News:Health News:New Diabetes Treatment Program Improves Health of Diabetes Patients and Their Families 2Health News:New Diabetes Treatment Program Improves Health of Diabetes Patients and Their Families 3Health News:New Diabetes Treatment Program Improves Health of Diabetes Patients and Their Families 4Health News:New Diabetes Treatment Program Improves Health of Diabetes Patients and Their Families 5Health News:HIV prevention strategy key to curbing epidemic and cutting long-term treatment costs 2Health News:HIV prevention strategy key to curbing epidemic and cutting long-term treatment costs 3Health News:Phoenix Dentist Joseph R. Cohen, D.D.S., is Chosen by The American Dental Association's Commission on Dental Accreditation as Site Visitor. 2Health News:Study finds patients benefit from thorough discussion of recommended operations 2Health News:Study finds patients benefit from thorough discussion of recommended operations 3Health News:Zone Labs' CEO Etholm Discusses Entrepreneurial Opportunity in America, on WMST Radio 2Health News:Doctor-Patient E-Mails Are a Healthy Addition, Research Shows 2Health News:Doctor-Patient E-Mails Are a Healthy Addition, Research Shows 3
... The pause of a heartbeat. The ... of rhythmic breathing. These vital signs are ... check. DeRoyals line of Temperature Monitoring products ... the information needed to provide the most ...
... pause of a heartbeat. The bodys warmth ... breathing. These vital signs are yours to ... line of Temperature Monitoring products helps you ... needed to provide the most comfortable and ...
... is a portable, compact, lightweight system with ... emitting the same intensity (50 mW/cm) of ... smaller treatment area (30 cm). Excilite- possesses ... satisfy the most demanding professional users. The ...
... Smart 1064 is a laser system with ... versions with maximum continuous intensities of either 60 ... valid ally in all-mini-invasive surgical techniques. This laser ... it is the most requested from hospitals and ...
Medicine Products: